Sorrento Therapeutics Inc (SRNE): I hope everyone listened to the Benzinga...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	57
Posts	5700
Boards Moderated	0
Alias Born	12/13/2004

dia76ca

Re: None

Thursday, 09/30/2021 11:00:57 AM

Thursday, September 30, 2021 11:00:57 AM

I hope everyone listened to the Benzinga panel where Dr.Ji and the CEO of DYAI discussed the advantage of using the C1 technology to produce anti-Covid antibodies.
Dr. Ji pointed out that compared to the Regeneron antibody Sorrento's CoviDrop antibody needed only 1/50th of the dose. Using the C1 technology Sorrento can produce 10 times as much antibody per run as conventional technologies. So put that together and Sorrento has a 500 fold production cost advantage over competitors!
Furthermore, Sorrento antibodies (all 3!) cover all current and potential future variants!
SORRENTO HAS CHEAPER AND MORE EFFECTIVE ANTIBODIES! Trials in US, UK and Brazil are already underway...and are being accelerated!

"The refusal of the real is the number one dogma of our time" Rene Girard

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM